HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Lodoxamide

HCID 44564
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
53882-12-5
Standard SMILES
N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1
InChIKey
RVGLGHVJXCETIO-UHFFFAOYSA-N
Molecular formula
C11H6ClN3O6
Average molar mass
311.63 g/mol
Monoisotopic mass
310.9945126

Overview

Lodoxamide is an organonitrogen compound and an organooxygen compound. It is functionally related to an alpha-amino acid.

Names & identifiers

Preferred name
Lodoxamide
IUPAC
2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid
English name
Lodoxamide
Molecular formula
C11H6ClN3O6
Molecular weight
311.63

Names & synonyms

Lodoxamide53882-12-5LodoxamidaLodoxamidumDTXSID9057767SPU695OD73DTXCID0031556N,N'-(2-chloro-5-cyano-m-phenylene)dioxamateAcetic acid, 2,2'-((2-chloro-5-cyano-1,3-phenylene)diimino)bis(2-oxo-{[3-(carboxyformamido)-2-chloro-5-cyanophenyl]carbamoyl}formic acidAcetic acid, 2,2'-[(2-chloro-5-cyano-1,3-phenylene)diimino]bis[2-oxo-((3-(carboxyformamido)-2-chloro-5-cyanophenyl)carbamoyl)formic acid
Show more names
Unii-spu695od73LODOXAMIDE USP/EP/BPLodoxamide (U42585E)Lodoxamide lmpurity 16Lodoxamide lmpurity 01Lodoxamidum [inn-latin]Lodoxamida [inn-spanish]Lodoxamide, 10 mM in DMSO
2-((2-chloro-5-cyano-3-(oxaloamino)phenyl)amino)-2-oxoacetic acid2-[[2-chloro-5-cyano-3-(oxaloamino)phenyl]amino]-2-oxoacetic acidRefChem:58567S01GX052-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid2,2'-((2-Chloro-5-cyano-1,3-phenylene)bis(azanediyl))bis(2-oxoacetic acid)U-42585E (free acid)Lodoxamide (INN)

Properties

Computed structural propertiesFilling in

XLogP
0.5
Topological polar surface area
157 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
7
Rotatable bonds
4
Heavy atoms
21
Formal charge
0
Complexity
489

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Allergic Agents; Histamine Antagonists

Physicochemical properties

Melting point
212 ° · 212° (dec)
Density
1.78 · 1.78±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
3 mg/ml; · DMF: 3 mg/ml; DMSO: 5 mg/ml; PBS (pH 7.2): 2 mg/mL
form
A solid
pka
2.07 · 2.07±0.50(Predicted)
color
Off-white to pink
Stability
Hygroscopic
InChI
1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21)
InChIKey
RVGLGHVJXCETIO-UHFFFAOYSA-N

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
WGK 3
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 3 items

S01GX05

S - Sensory organs

QS - Sensory organs

Pharmacodynamics · 1 item

Lodoxamide is a mast cell stabilizer that inhibits the in vivo Type 1 immediate hypersensitivity reaction. Lodoxamide therapy inhibits the increases in cutaneous vascular permeability that are associated with reagin or IgE and antigen-mediated reactions.

Mechanism of Action · 1 item

Although lodoxamide's precise mechanism of action is unknown, it is postulated that it prevents calcium influx into mast cells upon antigen stimulation and therefore stabilizes the membrane. By stabilizing the mast cell membrane from degranulation, lodoxamide consequently inhibits the release of intracellular histamine and other chemoattractant factors that primarily cause ocular symptoms. Lodoxamide's mechanism of action may be similar to cromolyn sodium, as both exhibit cross-tachyphylaxis.

Biological Half-LifeElimination half-life was 8.5 hours in urine.
FDA Pharmacological Classification · 5 items

SPU695OD73

LODOXAMIDE

Physiologic Effects [PE] - Decreased Histamine Release

Established Pharmacologic Class [EPC] - Mast Cell Stabilizer

Lodoxamide is a Mast Cell Stabilizer. The physiologic effect of lodoxamide is by means of Decreased Histamine Release.

MeSH Pharmacological Classification · 1 item

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Absorption, Distribution and Excretion · 2 items

In a study of twelve healthy adult volunteers, topical administration of lodoxamide tromethamine ophthalmic solution 0.1%, one drop in each eye four times per day for ten days, did not result in any measurable lodoxamide plasma levels at a detection limit of 2.5 ng/mL.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
53882-12-5
PubChem CID
44564
DTXSID
DTXSID9057767
ChEMBL
CHEMBL1201266
ChEBI
CHEBI:135333
UNII
SPU695OD73
Nikkaji
J10.842A
SMILES
Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O
FDA UNII
695 OD73 · SPU695OD73
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids

Urinary excretion is the major route of elimination.

Applications · 3 items

DescriptionTrometamol (2-amino-2-(hydroxymethyl)-1,3- propanediol) salt . Lodoxamide is an antiallergic drug acting as a mast-cell stabilizer, which is effective in the treatment of allergic conjunctivitis .

UsesLodoxamide is an antiallergic drug that acts as a mast cell stabilizer. It is effective in the treatment of allergic conjunctivitis and in decreasing vascular permeability.

UsesHarmful

Upstream & downstream products

Upstream raw materials

4-Chloro-3,5-dinitrobenzoic acidEthyl chlorooxoacetateStannous chloride dihydrate4-CHLORO-3,5-DINITROBENZONITRILE

Additional notes

DefinitionChEBI: Lodoxamide is an organooxygen compound and an organonitrogen compound. It is functionally related to an alpha-amino acid.